Management of Hypercholesterolemia in Childhood and Adolescence

Heart Disease

Volumn 2, Issue 5, 2000, Pages 348-353

  Kronn, D F ^a   Sapru, A ^a   Satou, G M ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOCHOLESTEROLEMIC AGENT;

ADOLESCENT; CHILD; DIET THERAPY; HUMAN; HYPERCHOLESTEROLEMIA; LOW FAT DIET; REVIEW;

ADOLESCENT; ANTICHOLESTEREMIC AGENTS; CHILD; DIET, FAT-RESTRICTED; HUMAN; HYPERCHOLESTEROLEMIA;

EID: 0034279041     PISSN: 1521737X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Haust MD. Atherosclerosis in childhood. Perspect Pediatr Pathol 1978;4:155-216.
2. Lauer R. Coronary disease prevention should begin in childhood. Iowa Med 1992;82:329-331.
3. Lauer RM. Should children, parents, and pediatricians worry about cholesterol? Pediatrics 1992;89:509-511.
4. Gidding SS. Preventive pediatric cardiology. Tobacco, cholesterol, obesity and physical activity. Pediatr Clin North Am 1999;46:253-262.
5. Newburger JW. Dyslipidemia in Childhood and Adolescence. In: Flyer DC, ed. Nadas' Pediatr Cardiol 1994:285-293.
6. Strong WB, Dennison BA. Pediatric preventive cardiology: atherosclerosis and coronary heart disease. Pediatr Rev 1988;9:303-314.
7. Vubecky JS, Grant AM, Laplante P, et al. Hypercholesterolaemia in childhood: repercussions in adulthood. Eur J Clin Nutr 1993;47(Suppl 1):S47-S56.
8. Ilhagworth DR. Management of hypercholesterolemia. Med Clin North Am 2000;84:23-42.
9. Arneson T, Luepker R, Pirie P, et al. Cholesterol screening by primary care pediatricians: a study of attitudes and practices in the Minneapolis-St. Paul metropolitan area. Pediatrics 1992;89:502-505.
10. National Cholesterol Education Program (NCEP). Highlights of the report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics 1992;89:495-501.
11. American Academy of Pediatrics. National Cholesterol Education Program: Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics 1992;89:525-584.
12. Fisher EA, Van Horn L, McGill HC Jr. Nutrition and children. A statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 1997;95:2332-2333.
13. Dennison BA, Kikuchi DA, Srinivasan SR, et al. Parental history of cardiovascular disease as an indication for screening for lipoprotein abnormalities in children. J Pediatr 1989;115:186-194.
14. Dennison BA, Kikuchi DA, Srinivasan SR, et al. Serum total cholesterol screening for the detection of elevated low-density lipoprotein in children and adolescents: the Bogalusa Heart Study. Pediatrics 1990;85:472-479.
15. Griffin TC, Christoffel KK, Binns HJ, et al. Family history evaluation as a predictive screen for childhood hypercholesterolemia. Pediatric Practice Research Group. Pediatrics 1989;84:365-373.
16. Resnicow K, Cross D. Are parents' self-reported total cholesterol levels useful in identifying children with hyperlipidemia? An examination of current guidelines. Pediatrics 1993;92:347-353.
17. Rifai N, Neufeld E, Ahlstrom P, et al. Failure of current guidelines for cholesterol screening in urban African-American adolescents. Pediatrics 1996;98:383-388.
18. Guidelines for using serum cholesterol, high-density lipoprotein cholesterol, and triglyceride levels as screening tests for preventing coronary heart disease in adults. American College of Physicians. Part 1. Ann Intern Med 1996;124:515-517.
19. Garber AM, Browner WS, Hulley SB. Cholesterol screening in asymptomatic adults, revisited. Part 2. Ann Intern Med 1996;124:518-531.
20. Newman TB. Cholesterol screening in children and adolescents. Pediatrics 2000;105:637-638.
21. Aggett PJ, Haschke F, Heine W, et al. Committee report: childhood diet and prevention of coronary heart disease. ESPGAN Committee on Nutrition. European Society of Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr 1994;19:261-269.
22. Berenson GS. Prevention of heart disease beginning in childhood through comprehensive school health: the Heart Smart Program. Prev Med 1993;22: 507-512.
23. Diagnosis and treatment of primary hyperlipidemia in childhood. A Joint Statement for Physicians by the Committee on Atherosclerosis and Hypertension in Childhood of the Council of Cardiovascular Disease in the Young and the Nutrition Committee, American Heart Association. Circulation 1986;74: 1181A-1188A.
24. Krauss RM, Deckelbaum RJ, Ernst N, et al. Dietary guidelines for healthy American adults. A statement for health professionals from the Nutrition Committee, American Heart Association. Circulation 1996;94:1795-1800.
25. Williams CL. Prevention of Coronary Artery Disease. In: Gewitz MH, ed. Primary Pediatric Cardiology. Armonk, NY: Futura Publishing Co., Inc., 1995: 425-466.
26. Williams CL. Nutrition Management of Hyperlipidemia. In: Williams CP, ed. Pediatric Manual of Clinical Dietetics. Chicago, IL: American Dietetic Association; 1998:265-283.
27. Quivers ES, Driscoll DJ, Garvey CD, et al. Variability in response to a low-fat, low-cholesterol diet in children with elevated low-density lipoprotein cholesterol levels. Pediatrics 1992;89:925-929.
28. Fitch J, Garcia RE, Moodie DS, Secic M. Influence of cholesterol screening and nutritional counseling in reducing cholesterol levels in children. The American Heart Association. Clin Pediatr (Phila) 1997;36:267-272.
29. Nader PR, Sallis JF, Patterson TL, et al. A family approach to cardiovascular risk reduction: results from the San Diego Family Health Project. Health Educ Q 1989;16:229-244.
30. Vega WA, Sallis JF, Patterson T, et al. Assessing knowledge of cardiovascular health-related diet and exercise behaviors in Anglo- and Mexican-Americans. Prev Med 1987;16:696-709.
31. Nader PR, Baranowski T, Vanderpool NA, et al. The family health project: cardiovascular risk reduction education for children and parents. J Dev Behav Pediatr 1983;4:3-10.
32. Ducobu J, Brasseur D, Chaudron JM, et al. Simvastatin use in children [letter]. Lancet 1992;339:1488.
33. Sprecher DL, Daniels SR. Rational approach to pharmacologic reduction of cholesterol levels in children [editorial; comment]. J Pediatr 1996;129:4-7.
34. Tonstad S. A rational approach to treating hypercholesterolaemia in children. Weighing the risks and benefits. Drug Saf 1997;16:330-341.
35. Becker M, Staab D, Von Bergman K. Long-term treatment of severe familial hypercholesterolemia in children: effect of sitosterol and bezafibrate. Pediatrics 1992;89:138-142.
36. McCrindle BW, O'Neill MB, Cullen-Dean G, et al. Acceptability and compliance with two forms of cholestyramine in the treatment of hypercholesterolemia in children: a randomized, crossover trial. J Pediatr 1997;130:266-273.
37. Stein EA. Drug therapy in children and adolescents with familial hypercholesterolemia. Prog Clin Biol Res 1988;255:273-280.
38. Tonstad S, Knudtzon J, Sivertsen M, et al. Efficacy and safety of cholestyramine therapy in peripubertal and prepubertal children with familial hypercholesterolemia. J Pediatr 1996;129:42-49.
39. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998;339:1349-1357.
40. Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 1998;279:1615-1622.
41. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med 1996;335: 1001-1009.
42. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 1995;333:1301-1307.
43. Stein EA, Illingworth DR, Kwiterovich PO Jr, et al. Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial. JAMA 1999;281:137-144.
44. Stein EA. Management of hypercholesterolemia. Approach to diet and drug therapy. Am J Med 1989;87(Suppl 4A):20S-27S.
45. Knipscheer HC, Boelen CC, Kastelein JJ, et al. Short-term efficacy and safety of pravastatin in 72 children with familial hypercholesterolemia. Pediatr Res 1996; 39:867-871.
46. Lambert M, Lupien PJ, Gagne C, et al. Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Canadian Lovastatin in Children Study Group. Pediatrics 1996;97:619-628.
47. Stefanutti C, Vivenzio A, Colombo C, et al. Treatment of homozygous and double heterozygous familial hypercholesterolemic children with LDL-apheresis. Int J Artif Organs 1995;18:103-110.
48. Barter PJ, O'Brien RC. Achievement of target plasma cholesterol levels in hypercholesterol-aemic patients being treated in general practice. Atherosclerosis 2000;149:199-205.
49. Bakker-Arkema RG, Nawrocki JW, Black DM. Safety profile of atorvastatin-treated patients with low LDL-cholesterol levels. Atherosclerosis 2000;149:123-129.
50. Farnier M, Portal JJ, Maigret P. Efficacy of atorvastatin compared with simvastatin in patients with hypercholesterolemia. J Cardiovasc Pharmacol Ther 2000; 5:27-32.